SuperworthuniQure PE ratio QURE
Share price divided by earnings per share over the last twelve months, since 2021.
- Today, Oct 23, 2026
- n/m
- losses over the last year
- Last meaningful
- 3.7×
- Aug 2022
- Peer median
- 12.5×
uniQure has no meaningful PE ratio today: it lost $4.05 a share over the last twelve months, and a PE needs earnings.
It was last meaningful in Aug 2022, at 3.7×.
PE ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2022 | 3.7× | 2.0× | 3.7× |
| 2021 | 3.1× | 3.1× | 5.8× |
Against its peers
Companies in Drug Manufacturers - General nearest uniQure's size, closest first, today.
| Company | PE ratio |
|---|---|
| QUREuniQure | n/m |
| PAHCPhibro Animal Health | 15.9× |
| ANABAnaptysbio | 10.7× |
| PCRXPacira BioSciences | 104× |
| ANIPANI Pharmaceuticals | 15.4× |
| OMEROmeros | 10.9× |
| HRMYHarmony Biosciences | 11.7× |
| AMPHAmphastar Pharmaceuticals | 14.8× |
| PBHPrestige Consumer Healthcare | 13.4× |
| NRIXNurix Therapeutics | 11.0× |
| ABUSArbutus Biopharma | 5.4× |
| Peer median | 12.5× |
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on uniQure
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.